Differences in oxazolidinone resistance mechanisms and small colony variants emergence of Staphylococcus aureus induced in an in vitro resistance development model

References

• Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–532. doi:10.1056/NEJM199808203390806
   PubMed Web of Science ®Google Scholar
• Dombrowski JC, Winston LG. Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections. J Infect. 2008;57(2):110–115. doi:10.1016/j.jinf.2008.04.003
   PubMed Web of Science ®Google Scholar
• Shenoy ES, Macy E, Rowe T, et al. Evaluation and management of Penicillin allergy: a review. Jama. 2019;321(2):188–199. doi:10.1001/jama.2018.19283
   PubMed Web of Science ®Google Scholar
• Li J, et al. Linezolid vs. vancomycin in treatment of methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Eur Rev Med Pharmacol Sci. 2017;21(17):3974–3979.
   PubMed Web of Science ®Google Scholar
• Turner NA, Moehring R, Sarubbi C, et al. Influence of reported Penicillin allergy on mortality in MSSA bacteremia. Open Forum Infect Dis. 2018;5(3):ofy042. doi:10.1093/ofid/ofy042
   PubMed Web of Science ®Google Scholar
• Willekens R, Puig-Asensio M, Ruiz-Camps I, et al. Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study. Clin Infect Dis. 2019;69(3):381–387. doi:10.1093/cid/ciy916
   PubMed Web of Science ®Google Scholar
• Bai AD, Lo CKL, Komorowski AS, et al. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(8):1076–1084. doi:10.1016/j.cmi.2022.03.015
   PubMed Web of Science ®Google Scholar
• Diep BA, Afasizheva A, Le HN, et al. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J Infect Dis. 2013;208(1):75–82. doi:10.1093/infdis/jit129
   PubMed Web of Science ®Google Scholar
• Katahira EJ, Davidson SM, Stevens DL, et al. Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2019;68(2):255–262. doi:10.1099/jmm.0.000905
   PubMed Web of Science ®Google Scholar
• Stevens DL, Ma Y, Salmi D, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195(2):202–211. doi:10.1086/510396
   PubMed Web of Science ®Google Scholar
• Tong SYC, Mora J, Bowen AC, et al. The Staphylococcus aureus network adaptive platform trial protocol: new tools for an Old Foe. Clin Infect Dis. 2022;75(11):2027–2034. doi:10.1093/cid/ciac476
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Jensen SO, Vaska VL, et al. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012;25(2):362–386. doi:10.1128/CMR.05022-11
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2021. Version 11.0.
   Google Scholar
• Gurevich A, Saveliev V, Vyahhi N, et al. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29(8):1072–1075. doi:10.1093/bioinformatics/btt086
   PubMed Web of Science ®Google Scholar
• Prjibelski A, Antipov D, Meleshko D, et al. Using SPAdes De Novo Assembler. Curr Protoc Bioinformatic. 2020;70(1):e102. doi:10.1002/cpbi.102
   PubMedGoogle Scholar
• Koboldt DC, Zhang Q, Larson DE, et al. Varscan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568–576. doi:10.1101/gr.129684.111
   PubMed Web of Science ®Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–359. doi:10.1038/nmeth.1923
   PubMed Web of Science ®Google Scholar
• Alcock BP, Raphenya AR, Lau TT, et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 2020;48(D1):D517–d525.
   PubMed Web of Science ®Google Scholar
• Bartels MD, Petersen A, Worning P, et al. Comparing whole-genome sequencing with Sanger sequencing for spa typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2014;52(12):4305–4308. doi:10.1128/JCM.01979-14
   PubMed Web of Science ®Google Scholar
• Bortolaia V, Kaas RS, Ruppe E, et al. Resfinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75(12):3491–3500. doi:10.1093/jac/dkaa345
   PubMed Web of Science ®Google Scholar
• Carattoli A, Zankari E, García-Fernández A, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895–3903. doi:10.1128/AAC.02412-14
   PubMed Web of Science ®Google Scholar
• Joensen KG, Scheutz F, Lund O, et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol. 2014;52(5):1501–1510. doi:10.1128/JCM.03617-13
   PubMed Web of Science ®Google Scholar
• Larsen MV, Cosentino S, Rasmussen S, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50(4):1355–1361. doi:10.1128/JCM.06094-11
   PubMed Web of Science ®Google Scholar
• Malberg Tetzschner AM, Johnson JR, Johnston BD, et al. In silico genotyping of Escherichia coli isolates for extraintestinal virulence genes by use of whole-genome sequencing data. J Clin Microbiol. 2020;58(10). doi:10.1128/JCM.01269-20
   PubMed Web of Science ®Google Scholar
• Zankari E, Allesøe R, Joensen KG, et al. Pointfinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72(10):2764–2768. doi:10.1093/jac/dkx217
   PubMed Web of Science ®Google Scholar
• Jian Y, Lv H, Liu J, et al. Dynamic changes of Staphylococcus aureus susceptibility to vancomycin, teicoplanin, and linezolid in a central teaching hospital in Shanghai, China, 2008-2018. Front Microbiol. 2020;11:908. doi:10.3389/fmicb.2020.00908
   PubMed Web of Science ®Google Scholar
• Markwart R, Willrich N, Eckmanns T, et al. Low proportion of linezolid and daptomycin resistance among bloodborne vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus infections in Europe. Front Microbiol. 2021;12:664199. doi:10.3389/fmicb.2021.664199
   PubMed Web of Science ®Google Scholar
• Shariati A, Dadashi M, Chegini Z, et al. The global prevalence of daptomycin, tigecycline, quinupristin/dalfopristin, and linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):56. doi:10.1186/s13756-020-00714-9
   PubMed Web of Science ®Google Scholar
• Rajkumar S, Sistla S, Manoharan M, et al. Prevalence and genetic mechanisms of antimicrobial resistance in Staphylococcus species: a multicentre report of the Indian council of medical research antimicrobial resistance surveillance network. Indian J Med Microbiol. 2017;35(1):53–60. doi:10.4103/ijmm.IJMM_16_427
   PubMed Web of Science ®Google Scholar
• Yoo IY, Kang O-K, Shim HJ, et al. Linezolid resistance in methicillin-resistant Staphylococcus aureus in Korea: high rate of false resistance to linezolid by the VITEK 2 system. Ann Lab Med. 2020;40(1):57–62. doi:10.3343/alm.2020.40.1.57
   PubMed Web of Science ®Google Scholar
• Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother. 2009;53(12):5265–5274. doi:10.1128/AAC.00871-09
   PubMed Web of Science ®Google Scholar
• Perlaza-Jiménez L, Tan KS, Piper SJ, et al. A structurally characterized Staphylococcus aureus evolutionary escape route from treatment with the antibiotic Linezolid. Microbiol. Spectrum. 2022;10(4):e00583–22.
   PubMed Web of Science ®Google Scholar
• Locke JB, Morales G, Hilgers M, et al. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3. Antimicrob Agents Chemother. 2010;54(12):5352–5355. doi:10.1128/AAC.00714-10
   PubMed Web of Science ®Google Scholar
• Shaw KJ, Poppe S, Schaadt R, et al. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains. Antimicrob Agents Chemother. 2008;52(12):4442–4447. doi:10.1128/AAC.00859-08
   PubMed Web of Science ®Google Scholar
• Shen T, Penewit K, Waalkes A, et al. Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage. J Antimicrob Chemother. 2021;76(2):292–296. doi:10.1093/jac/dkaa422
   PubMed Web of Science ®Google Scholar
• Kahl BC, Becker K, Löffler B. Clinical significance and pathogenesis of Staphylococcal small colony variants in persistent infections. Clin Microbiol Rev. 2016;29(2):401–427. doi:10.1128/CMR.00069-15
   PubMed Web of Science ®Google Scholar
• Proctor RA, von Eiff C, Kahl BC, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol. 2006;4(4):295–305. doi:10.1038/nrmicro1384
   PubMed Web of Science ®Google Scholar